HIGHLIGHTS
- who: Xiang-lin Hao from the Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing, China have published the article: TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer, in the Journal: (JOURNAL)
- what: Using a combination of TCGA database and bioinformatics the authors demonstrate that TC2N is involved in regulation of the p53 signaling pathway. The late diagnosis and lack of effective therapy are the main reasons leading to the poor prognosis of patients with lung cancer . The authors examined the expression of TC2N in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.